Versantis AG
🇨🇭Switzerland
- Country
- 🇨🇭Switzerland
- Ownership
- Subsidiary
- Established
- 2015-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://versantis.com
Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)®
Phase 2
Recruiting
- Conditions
- AscitesAcute-On-Chronic Liver Failure
- Interventions
- Drug: VS-01 on top of SOCOther: SOC (Control Group)
- First Posted Date
- 2023-06-12
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- Versantis AG
- Target Recruit Count
- 60
- Registration Number
- NCT05900050
- Locations
- 🇫🇷
Centre Hospitalier Régional Universitaire de Tours, Chambray-lès-Tours, France
🇫🇷Hôpital de la Croix Rousse, Lyon, France
🇫🇷CHU Rennes - Hôpital Pontchaillou, Rennes, France
© Copyright 2025. All Rights Reserved by MedPath